ANPAC BIO-MED SP.ADS/20 A

Depository Receipt · US03635R2067 · ANPC (LSSI)

No Price

n/a

Company Profile for ANPAC BIO-MED SP.ADS/20 A Depository Receipt

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Get up to date insights from finAgent about ANPAC BIO-MED SP.ADS/20 A

Company Data

Name ANPAC BIO-MED SP.ADS/20 A

Company AnPac Bio-Medical Science Co., Ltd.

Symbol ANPC

Website https://www.anpacbio.com

Primary Exchange

Lang & Schwarz

ISIN US03635R2067

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Chris Chang Yu

Market Capitalization 27 Mio

Country China

Currency EUR

Employees 0,1 T

Address 801 Bixing Street, 323006 Lishui

IPO Date 2020-01-30

Ticker Symbols

Name	Symbol
Frankfurt	0UC0.F
NASDAQ	ANPC

More Shares

Investors who hold ANPAC BIO-MED SP.ADS/20 A also have the following shares in their portfolio:

BMO MSCI USA ESG Leaders Index ETF ETF

LM FNDG. AMER. DL-,001 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog